In a significant stride towards equitable healthcare technology, MedCognetics, Inc., a company focusing on medical imaging AI, has been awarded a patent by the United States Patent and Trademark Office (USPTO) for its innovative approach to achieving unbiased artificial intelligence (AI) in breast imaging.
The patented technology, backed by peer-reviewed research and a grant from the National Institutes of Health (NIH), aims to mitigate biases in AI algorithms by incorporating architectural strategies and methodologies that maintain high performance across different patient demographics. This breakthrough is poised to redefine the development of AI in the medical field, ensuring consistent, fair, and superior patient outcomes.
‘This patent is a reflection of our team’s focused pursuit of innovation and commitment to inclusivity,’ said Ron Nag, CEO of MedCognetics, Inc. ‘Our technology is not just about improving patient outcomes through earlier and more accurate diagnoses; the focus is on fostering equality in technological development and ensuring universal access to advancements in healthcare systems worldwide.’
MedCognetics is actively engaged in partnerships with leading healthcare institutions and research organizations to bring its patented AI technology into clinical practice, aiming for widespread patient benefit from these advancements at the earliest. The company’s AI software platform integrates into radiology workflows and is trained on a diverse global patient dataset to mitigate data biasing, positioning it at the forefront of creating more predictable medical outcomes and ultimately saving lives.
For further information about MedCognetics and its pioneering medical imaging AI technology, please visit www.medcognetics.com.
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is MedCognetics Pioneers Unbiased AI for Inclusive Breast Cancer Screening.